Diagnostic and prognostic value of Doppler echocardiographic coronary flow reserve in the left anterior descending artery

Heart

Volumn 97, Issue 21, 2011, Pages 1758-1765

  Cortigiani, Lauro ^a   Rigo, Fausto ^b   Galderisi, Maurizio ^c   Gherardi, Sonia ^d   Bovenzi, Francesco ^a   Picano, Eugenio ^e   Sicari, Rosa ^e  

^a CAMPO DI MARTE HOSPITAL   (Italy)

^b Umberto I Hospital   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Cesena Hospital   (Italy)

^e INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE;

ADULT; AGED; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE WALL MOTION; HUMAN; HYPERTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; DIPYRIDAMOLE; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; VASODILATOR AGENTS;

EID: 80053639278     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300178     Document Type: Article

References (42)

1. Mancia G, De Backer G, Dominiczak A, et al Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87. (Pubitemid 46924065)
2. Graham I, Atar D, Borch-Johnsen K, et al European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; (14 Suppl 2):E1-40.
3. Melin JA, Piret LJ, Vanbutsele RJ, et al. Diagnostic value of exercise electrocardiography and thallium myocardial scintigraphy in patients without previous myocardial infarction: a Bayesian approach. Circulation 1981;63:1019-24. (Pubitemid 11106366)
4. Schulman DS, Francis CK, Black HR, et al. Thallium-201 stress imaging in hypertensive patients. Hypertension 1987;10:16-21. (Pubitemid 17104007)
5. Vogt M, Motz W, Strauer BE. Coronary haemodynamics in hypertensive heart disease. Eur Heart J 1992;(13 Suppl D):44-9.
6. Lucarini AR, Picano E, Lattanzi F, et al. Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools. Circulation 1991;83(Suppl 5): III68-72.
7. Picano E, Lucarini AR, Lattanzi F, et al. Dipyridamole echocardiography in essential hypertensive patients with chest pain. Hypertension 1988;12:238-43.
8. Cortigiani L, Bigi R, Rigo F, et al. Diagnostic value of exercise electrocardiography and dipyridamole stress echocardiography in hypertensive and normotensive chest pain patients with right bundle branch block. J Hypertens 2003;21:2189-94. (Pubitemid 38296882)
9. Fragasso G, Lu C, Dabrowski P, et al. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J Am Coll Cardiol 1999;34:441-7.
10. Astarita C, Pálinkás A, Nicolai E, et al. Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test. J Hypertens 2001;19:495-502. (Pubitemid 32195386)
11. Cortigiani L, Paolini EA, Nannini E. Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain. Circulation 1998;98:2855-9. (Pubitemid 29003967)
12. Marwick TH, Case C, Sawada S, et al. Prediction of outcomes in hypertensive patients with suspected coronary disease. Hypertension 2002;39:1113-18. (Pubitemid 34620133)
13. Hozumi T, Yoshida K, Akasaka T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 1998;32:1251-9. (Pubitemid 28522380)
14. Caiati C, Montaldo C, Zedda N, et al. New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 1999;99:771-8. (Pubitemid 29083017)
15. Daimon M, Watanabe H, Yamagishi H, et al. Physiologic assessment of coronary artery stenosis by coronary flow reserve measurements with transthoracic Doppler echocardiography: comparison with exercise thallium-201 single positron emission computed tomography. J Am Coll Cardiol 2001;37:1310-15.
16. Rigo F, Richieri M, Pasanisi E, et al. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol 2003;91:269-73. (Pubitemid 36143864)
17. Rigo F, Sicari R, Gherardi S, et al. The additive prognostic value of wall motion abnormalities and coronary flow reserve during dipyridamole stress echo. Eur Heart J 2008;29:79-88.
18. Cortigiani L, Rigo F, Gherardi S, et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 2007;50:1354-61. (Pubitemid 47449732)
19. Sicari R, Rigo F, Cortigiani L, et al. Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. Am J Cardiol 2009;103:626-31.
20. Lucarini AR, Lattanzi F, Picano E, et al. Dipyridamole-echocardiography test in essential hypertensives with chest pain and angiographically normal coronary arteries. Am J Hypertens 1989;2:120-3. (Pubitemid 19055881)
21. Strauer BE. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 1979;44:999-1006. (Pubitemid 10200711)
22. Struijker-Boudier HA, Rosei AE, Bruneval P, et al. Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur Heart J 2007;28:2834-40. (Pubitemid 350233027)
23. Galderisi M, Capaldo B, Sidiropulos M, et al. Determinants of reduction of coronary flow reserve in patients with type 2 diabetes mellitus or arterial hypertension without angiographically determined epicardial coronary stenosis. Am J Hypertens 2007;20:1283-90. (Pubitemid 350161828)
24. Picano E, Pálinkás A, Amyot R. Diagnosis of myocardial ischemia in hypertensive patients. J Hypertens 2001;19:1177-83. (Pubitemid 32595272)
25. Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement from the European Association of Echocardiography. Eur J Echocardiogr 2008;9:415-37. (Pubitemid 351882130)
26. Cerqueira MD, Weissman NJ, Dilsizian V, et al American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42 (Pubitemid 34262671)
27. Picano E, Mathias W, Pingitore A, et al; on behalf of the EDIC Study Group. Safety and tolerability of dobutamineeatropine stress echocardiography: a prospective, large scale, multicenter trial. Lancet 1994;344:1190-2.
28. Picano E, Parodi O, Lattanzi F, et al. Assessment of anatomic and physiological severity of single-vessel coronary artery lesions by dipyridamole echocardiography. Comparison with positron emission tomography and quantitative arteriography. Circulation 1994;89:753-61. (Pubitemid 24056203)
29. Lauer MS, Blackstone EH, Young JB, et al. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999;34:618-20. (Pubitemid 29436163)
30. Cortigiani L, Zanetti L, Bigi R, et al. Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients. J Hypertens 2002;20:1423-9. (Pubitemid 34925688)
31. Ha JW, Juracan EM, Mahoney DW, et al. Hypertensive response to exercise: a potential cause for new wall motion abnormality in the absence of coronary artery disease. J Am Coll Cardiol 2002;39:323-7. (Pubitemid 34084640)
32. Bigi R, Bax JJ, van Domburg RT, et al. Simultaneous echocardiography and myocardial perfusion single photon emission computed tomography associated with dobutamine stress to predict long-term cardiac mortality in normotensive and hypertensive patients. J Hypertens 2005;23:1409-15. (Pubitemid 40933963)
33. Cortigiani L, Rigo F, Gherardi S, et al. Implication of the continuous prognostic spectrum of Doppler echocardiographic derived coronary flow reserve on left anterior descending artery. Am J Cardiol 2010;105:158-62.
34. Marcus ML. Importance of abnormalities in coronary flow reserve to the pathophysiology of left ventricular hypertrophy secondary to hypertension. Clin Cardiol 1989;12(12 Suppl 4):IV34-5.
35. Cicala S, de Simone G, Roman MJ, et al. Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study. Circulation 2007;116:143-50. (Pubitemid 47057519)
36. Rubinshtein R, Yang EH, Rihal CS, et al. Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur Heart J 2010;31:936-42.
37. Lanza GA, Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 2010;121:2317-25.
38. Vogel R, Indermühle A, Meier P, et al. Quantitative stress echocardiography in coronary artery disease using contrast-based myocardial blood flow measurements: prospective comparison with coronary angiography. Heart 2009;95:377-84.
39. Cortigiani L, Bigi R, Landi P, et al. Prognostic implication of stress echocardiography in 6214 hypertensive and 5328 normotensive patients. Eur Heart J 2011;32:1509-18.
40. Picano E, Sicari R. Risk stratification by stress echocardiography: a whiter shade of pale? Eur J Echocardiogr 2004;5:162-4. (Pubitemid 38779965)
41. Cortigiani L, Rigo F, Sicari R, et al. Prognostic correlates of combined coronary flow reserve assessment on left anterior descending and right coronary artery in patients with negative stress echocardiography by wall motion criteria. Heart 2009;95:1423-8.
42. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6. (Pubitemid 20176696)